Full Text
EE635 Direct Comparison of Prophylaxis Cost in Patients With Severe Hemophilia A With and Without Inhibitors With Hemostatic Agents Versus the Use of Emicizumab in Guatemala

Abstract

Authors

AM Leal Lopez SC Oliva Lara

Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×